Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The US Food and Drug Administration (FDA) is set to form new alliances to accelerate the development of medical countermeasures for the new coronavirus that emerged in Wuhan, China last month.

The regulator will work with interagency and international partners, product developers and global regulators. The focus is to develop and make available medical products to treat, mitigate, prevent and diagnose such outbreaks.

FDA is sharing process updates to aid developers and issuing important information for the public to help in the development of medical products.

The coronavirus currently lacks diagnostics and the FDA is collaborating with public health partners to advance and share reference materials for diagnostic development.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

FDA commissioner Stephen Hahn said: “We are actively leveraging the vast breadth of the FDA’s expertise and have begun employing the full range of our public health authorities to facilitate the development and availability of investigational medical products to help address this urgent public health situation.”

Meanwhile, Anti-Coronavirus Foundation has been established in Geneva, Switzerland to fund research for the development of a coronavirus vaccine.

To ensure transparency, the foundation will manage all transactions in CRON blockchain run by CryptOcean. Anyone can use the blockchain platform to send funds for research at the foundation.

Furthermore, information analytics company Elsevier has created a Novel Coronavirus Information Center, providing access to medical, clinical research and scientific information regarding the virus.